Pyxis Oncology, Inc. PYXS
2.86
(0.06)
(2.05%)
as of 25 Sep
- Market cap
- $250.2M
- P/E
- 0.0×
Follow PYXS
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | — | — | — | — | — | — |
P/S ratio |
0.00 | 0.00 | — | — | — | — | — | — |
P/FCF ratio |
0.00 | 0.00 | — | — | — | — | — | — |
P/Operating CF |
(6.85) | (4.73) | — | — | — | — | — | — |
P/B ratio |
1.34 | 0.76 | — | — | — | — | — | — |
Price to Tangible BV |
1.40 | 0.77 | — | — | — | — | — | — |
EV/Sales |
0.00 | 0.00 | — | — | — | — | — | — |
EV/EBITDA |
0.00 | 0.40 | — | — | — | — | — | — |
EV/Operating CF |
(0.05) | 0.65 | — | — | — | — | — | — |
EV/FCF |
(0.05) | 0.64 | — | — | — | — | — | — |
Quick Ratio |
3.23 | 7.26 | 4.69 | 5.71 | 14.76 | 2.19 | 26.86 | — |
Current Ratio |
3.41 | 7.49 | 4.84 | 5.90 | 14.90 | 2.20 | 26.88 | — |
Net Debt/EBITDA |
0.82 | 1.39 | 1.42 | 1.47 | 4.00 | 0.65 | 6.83 | — |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.08% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Asset Turnover |
0.11 | 0.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
0.80 | 0.75 | 0.96 | 0.74 | 0.47 | 0.79 | 0.81 | — |
Capex/Depreciation |
(0.01) | 0.08 | 2.35 | (9.03) | (0.83) | (3.16) | — | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| (91.43%) | (62.75%) | (51.51%) | (57.19%) | (61.85%) | 138.54% | 29.94% | — | |
| (64.03%) | (46.74%) | (38.32%) | (49.13%) | (52.37%) | (85.64%) | (27.99%) | — | |
ROIC |
0.00% | 0.00% | (1,041.19%) | 0.00% | 0.00% | 0.00% | 0.00% | — |
Return on Tangible Assets |
(135.02%) | (62.03%) | (66.65%) | (72.66%) | (29.11%) | (232.52%) | (14.56%) | — |
Average Days of Receivables |
0.00 | 0.00 | — | 0.00 | — | — | — | — |
Research and Development Expense of Revenue |
531.79% | 363.85% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Selling, General and Administrative Expense of Revenue |
160.15% | 157.44% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Intangible Assets out of Total Assets |
0.00 | 0.02 | 0.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
85.16% | 80.17% | 0.00% | 0.00% | 0.00% | 0.00% | — | — |
Graham Net Nets |
0.48 | 1.05 | — | — | — | — | — | — |
Graham Number |
0.00 | 0.00 | — | — | — | — | — | — |
Earnings Yield |
(112.17%) | (83.33%) | — | — | — | — | — | — |
Free Cash Flow Yield |
(88.87%) | (63.51%) | — | — | — | — | — | — |
Revenue per Share |
0.22 | 0.28 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF per Share |
(1.02) | (0.99) | (1.77) | (2.70) | (4.16) | (9.78) | (0.07) | — |
Capex per Share |
0.00 | 0.00 | (0.17) | (0.19) | (0.06) | (1.44) | 0.00 | — |
Free Cash Flow per Share |
(1.02) | (0.99) | (1.94) | (2.90) | (4.22) | (11.22) | (0.07) | — |
Cash per Share |
1.10 | 2.20 | 3.03 | 5.47 | 32.52 | 7.84 | 0.57 | — |
Shareholders Equity per Share |
0.86 | 2.07 | 3.15 | 4.87 | 30.77 | (15.17) | 0.56 | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
0.86 | 2.07 | 3.15 | 4.87 | 30.77 | (15.17) | 0.56 | — |
Free Cash Flow |
(63.51) | (57.91) | (77.43) | (95.73) | (35.87) | (11.57) | (2.24) | — |
Working Capital |
50.97 | 114.76 | 98.85 | 154.98 | 259.97 | 4.41 | 18.97 | — |
Capital Expenditures |
(0.01) | (0.24) | (6.73) | (6.40) | (0.54) | (1.48) | — | — |
Net Current Asset Value |
33.99 | 96.01 | 76.58 | 136.06 | 259.97 | (17.69) | 18.96 | — |
EV/EBIT |
0.00 | 0.42 | — | — | — | — | — | — |
Capex to Sales |
0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Net Profit Margin |
(574.55%) | (478.95%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Price to Operating Income |
0.00 | 0.00 | — | — | — | — | — | — |
| Other line items | ||||||||
Depreciation/Fixed assets |
0.19 | (0.32) | (0.24) | 0.06 | 0.64 | 0.43 | 0.00 | — |
Cash ROIC |
(58.73%) | (27.12%) | (33.50%) | (29.42%) | (6.76%) | 147.88% | (5.97%) | — |
Accounts Receivable Turnover |
0.00 | 0.00 | — | — | — | — | — | — |
Accounts Payable Turnover |
0.30 | 0.11 | 0.00 | 0.19 | 0.19 | 0.57 | 0.00 | — |
Inventory Turnover |
0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | — | — |
Average Days of Payables |
1,663.75 | 3,733.76 | 0.00 | 1,410.90 | 3,486.90 | 885.37 | 0.00 | — |
Days of Inventory on Hand |
0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | — | — |
Average Payables |
7.87 | 4.38 | 5.50 | 9.52 | 6.51 | 0.78 | 0.78 | — |
Average Assets |
124.35 | 165.45 | 192.55 | 245.70 | 145.09 | 14.98 | 9.90 | — |
Average Common Equity |
87.08 | 123.23 | 143.26 | 211.07 | 122.83 | (9.26) | (9.26) | — |
Columns are period end dates